Single-Cell Analysis Reveals a Critical Role for Macrophage Epsins in Regulating the Origin of Foam Cells in

Kulandaisamy Arulsamy1,2, Kui Cui3, Bo Zhu3

  • 1Basic and Translational Research Division, Department of Cardiology, Boston Children's Hospital, MA (K.A., X.G., K.G., L.Z., K. Chen).

Abstract

Insights

Macrophage epsin deletion significantly reduces atherosclerosis and foam cell formation in mice. This highlights macrophage epsins as a potential therapeutic target for treating atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cell Biology

Background:

  • Atherosclerosis is a chronic inflammatory disease involving lipid accumulation and plaque formation in arteries.
  • Dysfunctional vascular smooth muscle cells (VSMCs), fibroblasts, endothelial cells, and macrophages drive disease progression.
  • Macrophage-specific expression of epsins, proteins involved in endocytosis, accelerates atherosclerosis.

Purpose of the Study:

  • To investigate the role of macrophage epsins in atherosclerosis development.
  • To elucidate the cellular and molecular mechanisms regulated by macrophage epsins.

Main Methods:

  • Generated WT/Apoe-/- and LysM-DKO/Apoe-/- mice fed a Western diet.
  • Utilized single-cell RNA sequencing to analyze cellular and molecular changes.
  • Validated findings using metabolic profiling, qRT-PCR, immunostaining, and coculture experiments.

Main Results:

  • LysM-DKO/Apoe-/- mice showed reduced atherosclerotic foam cell formation.
  • Single-cell RNA sequencing identified VSMC and macrophage subpopulations involved in inflammation and transition.
  • Macrophage epsin deletion reversed endothelial dysfunction and suppressed inflammatory signaling (IL-1β, TNF-α).

Conclusions:

  • Macrophage epsin deletion limits foam cell formation and preserves VSMC and endothelial cell function.
  • Targeting macrophage epsins represents a potential therapeutic strategy for atherosclerosis.